Funding Rounds
Enterprise Therapeutics

Enterprise Therapeutics Series B (2018, $36M)

Enterprise Therapeutics

Developer of drugs to treat respiratory diseases.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series B

Raised Amount: $36.60M

Raised Date: 2018-12-01

Investors